In CKD, once-daily empagliflozin reduced progression of kidney disease or CV death at 2 y
EMPA-KIDNEY Collaborative Group; Herrington WG, Staplin N, Wanner C, et al. N Engl J Med. 2023;388:117-27. 36331190.
Saved in:
Published in | Annals of internal medicine Vol. 176; no. 3; p. JC26 |
---|---|
Main Authors | , |
Format | Journal Article |
Language | English |
Published |
United States
01.03.2023
|
Subjects | |
Online Access | Get more information |
Cover
Loading…
Abstract | EMPA-KIDNEY Collaborative Group; Herrington WG, Staplin N, Wanner C, et al.
N Engl J Med. 2023;388:117-27. 36331190. |
---|---|
AbstractList | EMPA-KIDNEY Collaborative Group; Herrington WG, Staplin N, Wanner C, et al.
N Engl J Med. 2023;388:117-27. 36331190. |
Author | Hsu, Chi-Yuan Kwong, Y Diana |
Author_xml | – sequence: 1 givenname: Y Diana surname: Kwong fullname: Kwong, Y Diana organization: University of California, San Francisco, San Francisco, California, USA (Y.D.K., C.H.) – sequence: 2 givenname: Chi-Yuan surname: Hsu fullname: Hsu, Chi-Yuan organization: University of California, San Francisco, San Francisco, California, USA (Y.D.K., C.H.) |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/36877974$$D View this record in MEDLINE/PubMed |
BookMark | eNo1j8tKxDAUQIMozkPBL5D7AVbbJM1jKXXU0QE3Krga0uR2jLZJaTqL-vUK6urAWRw4C3IYYkBCzor8UjIqrh4oy_I81wdkXpRMZ0zmfEYWKX38WKaoOiYzJpSUWvI5eVsHqB5vLiAGi5kzvp0Au97sWt-08csHGNDtLTroh7gbMCUfA8QGPr0LOIHzCU1CiANUr-DQjO9gRqAwnZCjxrQJT_-4JC-3q-fqPts83a2r601mKedjJutc6KZmQnONWhXCKY7Clo2VQhelEaxUwhXC1rQsNONSGSpNjVQIQ7W0dEnOf7v9vu7QbfvBd2aYtv-P9BsFrlAq |
ContentType | Journal Article |
DBID | CGR CUY CVF ECM EIF NPM |
DOI | 10.7326/J23-0009 |
DatabaseName | Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) |
DatabaseTitleList | MEDLINE |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | no_fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1539-3704 |
ExternalDocumentID | 36877974 |
Genre | Comment Journal Article |
GroupedDBID | --- ..I .55 .GJ .XZ 08G 1CY 23M 2WC 354 36B 39C 3O- 3V. 4.4 53G 5GY 5RE 5RS 6J9 7RV 7X7 88E 8C1 8F7 8FI 8FJ 8G5 8R4 8R5 AAKAS AAQOH AAQQT AARDX AAWTL AAYOK ABBLC ABCQX ABJNI ABOCM ABPMR ABUWG ACBNA ACGFO ACGFS ADBBV ADZCM AEGXH AENEX AERZD AFCHL AFFNX AFKRA AHJKT AHMBA AI. AIAGR ALIPV ALMA_UNASSIGNED_HOLDINGS AQUVI ASPBG AVWKF AZFZN AZQEC BCR BCU BEC BENPR BKEYQ BKNYI BLC BPHCQ BTJBQ BVXVI BZLQD C1A C45 CCPQU CGR CUY CVF DWQXO E3Z EBS ECM EIF EJD EMB EMOBN EX3 F5P FEDTE FYUFA G8K GNUQQ GUQSH H13 HMCUK HVGLF H~9 IH2 J5H K-O K9- L7B LPU M0R M0T M1P M2O M5~ MV1 MVM N4W NAPCQ NPM OBH OCB OFXIZ OGEVE OHH OHT OVD OVIDX P2P PCD PQQKQ PROAC PSQYO Q2X RWL RXW S0X SJFOW SJN SV3 TAE TEORI TPH TR2 TWZ UKHRP UKR VH1 VVN WH7 WOQ WOW X6Y X7M XOL YFH YOC YQJ YYP ZGI ZXP ZY1 ~H1 |
ID | FETCH-LOGICAL-c244t-7b069fb36949e9816d84e6c5fc76915a63586d16cb25193478a27abe266a297c2 |
IngestDate | Sat Sep 28 08:15:24 EDT 2024 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 3 |
Language | English |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c244t-7b069fb36949e9816d84e6c5fc76915a63586d16cb25193478a27abe266a297c2 |
PMID | 36877974 |
ParticipantIDs | pubmed_primary_36877974 |
PublicationCentury | 2000 |
PublicationDate | 2023-03-00 |
PublicationDateYYYYMMDD | 2023-03-01 |
PublicationDate_xml | – month: 03 year: 2023 text: 2023-03-00 |
PublicationDecade | 2020 |
PublicationPlace | United States |
PublicationPlace_xml | – name: United States |
PublicationTitle | Annals of internal medicine |
PublicationTitleAlternate | Ann Intern Med |
PublicationYear | 2023 |
References | 36331190 - N Engl J Med. 2023 Jan 12;388(2):117-127 |
References_xml | |
SSID | ssj0003828 |
Score | 2.4581413 |
Snippet | EMPA-KIDNEY Collaborative Group; Herrington WG, Staplin N, Wanner C, et al.
N Engl J Med. 2023;388:117-27. 36331190. |
SourceID | pubmed |
SourceType | Index Database |
StartPage | JC26 |
SubjectTerms | Cardiovascular Diseases Diabetes Mellitus, Type 2 - complications Diabetes Mellitus, Type 2 - drug therapy Humans Renal Insufficiency, Chronic - complications Renal Insufficiency, Chronic - drug therapy Risk Factors |
Title | In CKD, once-daily empagliflozin reduced progression of kidney disease or CV death at 2 y |
URI | https://www.ncbi.nlm.nih.gov/pubmed/36877974 |
Volume | 176 |
hasFullText | |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnZ3LT9swHMetAhLiMjH2HkM-7NaZNXHqxxFlQ6VsnADRE7JjG1XrUrSlmsZfv58faUsZiO0SVbHaRv643_7s3wuh90a4TFaZICCBjhQ0N0SA3UBEZnXf9YRWNkRbnLDBWTG86F90Ol-WopZmjd6vbv6aV_I_VOEecPVZsv9Adv6hcANeA1-4AmG4PorxUd0tjz_5WfLJh8Qof1Zh4Qd-NRm7yfQm5KqYmXfxhzisWIPD24ffxqYGNUjuGR-UXp53jTcHfXZj3r3l7F0UWR7H88PJHZf88a8U2jsCEVX1XOsHP2fRqT8mo1laiOmMIaeLIKt92-qiBC2KnYLnwhk7t6QVQpdkcFjGNPhVfeY0dJQc-m_ohbIIzRKm6--BE2WCcxl79zw8ulIpux1aQ2tceM078Sc36V-ZwtYyFh_2D_GxfYQttNm-bWVjEQyM0230JO0M8EHE_BR1bL2DNr-miX6GRkc1Btof8II1vsUaJ9Z4iTWeOhxZ48QaT3_g8hwH1lg1OMe_n6Ozw8-n5YCkxhikAmusIVz3mHSaMllIK0XGjCgsq_qu4kxmfQVGpGAmY5X2ecm04ELlXGkLxpjKJa_yF2i9ntb2FcKg35lU0veO9ZZoJYziKuNWUico1_Y1ehkn5fI6Vj-5bKfrzb0jb9HWYhHtog0Ha9S-A9ut0XsByh_VL0Cx |
link.rule.ids | 783 |
linkProvider | National Library of Medicine |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=In+CKD%2C+once-daily+empagliflozin+reduced+progression+of+kidney+disease+or+CV+death+at+2+y&rft.jtitle=Annals+of+internal+medicine&rft.au=Kwong%2C+Y+Diana&rft.au=Hsu%2C+Chi-Yuan&rft.date=2023-03-01&rft.eissn=1539-3704&rft.volume=176&rft.issue=3&rft.spage=JC26&rft_id=info:doi/10.7326%2FJ23-0009&rft_id=info%3Apmid%2F36877974&rft_id=info%3Apmid%2F36877974&rft.externalDocID=36877974 |